Treatment of peripheral arterial occlusive disease

Details for Australian Patent Application No. 2006302429 (hide)

Owner ActivBiotics Pharma, LLC

Inventors Sternlicht, Andrew

Agent Blake Dawson Patent Attorneys

Pub. Number AU-A-2006302429

PCT Pub. Number WO2007/044435

Priority 60/735,969 10.11.05 US; 60/724,857 06.10.05 US

Filing date 5 October 2006

Wipo publication date 19 April 2007

International Classifications

A61K 31/33 (2006.01) - Heterocyclic compounds

A61K 31/70 (2006.01) - Carbohydrates

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/044435 Priority application(s): WO2007/044435

22 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006302435-Use of pyrazolo [1 , 5 -a] pyrimidine derivatives for inhibiting protein kinases methods for inhibiting protein kinases

2006302415-Azetidines as MEK inhibitors for the treatment of proliferative diseases